Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
12/29/1999 | WO1999055830A3 Process for synthesizing cox-2 inhibitors |
12/29/1999 | WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
12/29/1999 | WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
12/29/1999 | WO1999044597A3 Use of macrolide compounds for the treatment of ards |
12/29/1999 | EP0967284A1 Phosphodiesterases |
12/29/1999 | EP0967207A1 Nitrone derivatives, process for their preparation and pharmaceutical compositions containing them |
12/29/1999 | EP0966969A1 Anti-stress drugs and functional foods having anti-stress effects |
12/29/1999 | EP0966968A1 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 |
12/29/1999 | EP0966965A1 Methods for reducing levels of homocysteine and C-reactive protein |
12/29/1999 | EP0966964A1 Methods for increasing levels of acetylcholine |
12/29/1999 | EP0966536A1 Factor x analogues with a modified protease cleavage site |
12/29/1999 | EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii) |
12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
12/29/1999 | EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
12/29/1999 | EP0966487A1 Polyvalent carbohydrate molecules |
12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
12/29/1999 | EP0966476A1 Quinazolinone compounds |
12/29/1999 | EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
12/29/1999 | EP0966465A1 Inhibitors of impdh enzyme |
12/29/1999 | EP0966463A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
12/29/1999 | EP0966455A1 Oxiran carboxylic acids for the treatment of diabetes |
12/29/1999 | EP0966447A1 Small molecules useful in the treatment of inflammatory disease |
12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
12/29/1999 | EP0966442A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
12/29/1999 | EP0966438A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases |
12/29/1999 | EP0966437A1 5-aroylnaphthalene derivatives |
12/29/1999 | EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes |
12/29/1999 | EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds |
12/29/1999 | EP0966299A2 Novel pharmaceutical compositions |
12/29/1999 | EP0966295A1 Calcareous material |
12/29/1999 | EP0966294A1 Bifurcated method to process aloe whole leaf |
12/29/1999 | EP0966293A1 Medicine for promoting cicatrization and containing thrombocytes |
12/29/1999 | EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration |
12/29/1999 | EP0966286A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
12/29/1999 | EP0966283A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
12/29/1999 | EP0966277A1 Use of r-nsaid's for the prevention of alzheimer's disease |
12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
12/29/1999 | EP0785932B1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
12/29/1999 | EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES |
12/29/1999 | CN1239964A Tetraphosphonate bicyclic trisanhydrides |
12/29/1999 | CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
12/29/1999 | CN1239950A New derivates from piperidine-keto acid, their preparation and use |
12/29/1999 | CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases |
12/29/1999 | CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs. |
12/29/1999 | CN1239894A Inositol polyphosphate derivatives and method of using same |
12/29/1999 | CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound |
12/29/1999 | CN1239888A Method for inhibiting stress-activated protein kinases |
12/29/1999 | CN1239886A Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent |
12/29/1999 | CN1239718A 11-acetyl-12,13-dioxa bicyclo [8.2.1] tridecenone -derivative, its preparation and medicine containing the compound |
12/29/1999 | CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition |
12/29/1999 | CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
12/29/1999 | CA2336201A1 Compositions and methods for inhibiting bone resorption |
12/29/1999 | CA2336192A1 Compositions and methods for treating elevated blood cholesterol |
12/29/1999 | CA2336160A1 Use of compounds for treating hiv |
12/29/1999 | CA2336135A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
12/29/1999 | CA2336003A1 Amidino and guanidino azetidinone tryptase inhibitors |
12/29/1999 | CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
12/29/1999 | CA2335989A1 Stable no-delivering compounds |
12/29/1999 | CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
12/29/1999 | CA2335939A1 Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient |
12/29/1999 | CA2335876A1 Protease inhibitors |
12/29/1999 | CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
12/29/1999 | CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
12/29/1999 | CA2335711A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
12/29/1999 | CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
12/29/1999 | CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
12/29/1999 | CA2335329A1 Meiosis regulating compounds |
12/29/1999 | CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
12/29/1999 | CA2335190A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
12/29/1999 | CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
12/29/1999 | CA2333750A1 Adjuvant therapy |
12/29/1999 | CA2333586A1 Matrix-type transdermal patch for steroid hormones |
12/29/1999 | CA2330542A1 Human arf-related proteins |
12/29/1999 | CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
12/29/1999 | CA2330175A1 Ependymal neural stem cells and method for their isolation |
12/29/1999 | CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival |
12/29/1999 | CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
12/29/1999 | CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
12/29/1999 | CA2325389A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
12/29/1999 | CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
12/29/1999 | CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds |
12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
12/29/1999 | CA2294075A1 Herbal extract composition and method with immune-boosting capability |
12/28/1999 | US6008417 Oxidative dehydroxylation, oxidative cleaving, intramolecular aldol condensation, silylation, c3-chain lengthening and simultaneous saponification, reaction with vinylmagnesium bromide, deprotection, and wittig reaction |
12/28/1999 | US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin |
12/28/1999 | US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents |
12/28/1999 | US6008336 Compacted nucleic acids and their delivery to cells |
12/28/1999 | US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent |
12/28/1999 | US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases |
12/28/1999 | US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues |
12/28/1999 | US6008233 (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
12/28/1999 | US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators |
12/28/1999 | US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain |